ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1494 National Cancer Institute Html en Urethral Cancer Treatment (PDQ®)–Health Professional Version Expert-reviewed information summary about the treatment of urethral cancer.
female urethral cancer0.376591
major academic centers0.28402
lymph node dissection0.342065
urinary tract tumors0.271423
annual incidence rates0.28547
transitional cell carcinoma0.949088
PDQ cancer information0.378892
distal urethra0.410475
commonly used tumor0.321815
adjunctive radiation therapy0.307204
cancer information summary0.365437
definitive radiation0.299917
2-cm tumor-free margin0.279143
inguinal node dissection0.345806
inguinal nodes0.299311
anterior urethral carcinoma0.459736
NCI PDQ cancer0.276687
ipsilateral node dissection0.459423
female urethra0.380147
urethral catheter0.320637
radiation therapy0.634648
urethral cancer0.577855
patient selection0.261945
tumor margins0.303956
single-center case series0.440822
transitional cell mucosa0.339607
ipsilateral palpable adenopathy0.268507
urethral neoplasms0.326534
2-cm margin proximal0.288589
anterior vaginal wall0.284136
node dissection0.66141
anterior urethral cancers0.391992
prostatic urethra0.421315
proximal urethral cancers0.428057
Intensity-modulated radiation therapy0.317055
large tumors0.285311
poor tumor control0.307048
low-dose-rate iridium-192 sources0.265079
frozen section confirmation0.398049
End Results database0.287533
inguinal adenopathy0.28947
urethral cancers0.578678
optimal surgical margin0.277613
tumor0.331558
stratified squamous epithelium0.325971
pendulous urethra0.304701
numerous periurethral glands0.276798
inferior pubic rami0.262509
low level0.288208
CLICK HERE
1625 National Cancer Institute Html en Vulvar Cancer Treatment (PDQ®)–Patient Version Expert-reviewed information summary about the treatment of vulvar cancer.
clinical trial0.306795
treatment0.33468
vulvar cancer0.816472
lymph node biopsy0.279435
vulvar intraepithelial neoplasia0.273676
sentinel lymph node0.432305
cancer cells0.248189
Recurrent vulvar cancer0.242509
PDQ cancer information0.200769
Radical local excision0.22415
cancer clinical trials0.214832
lymph nodes0.572468
radiation therapy0.379761
National Cancer Institute0.219981
cancer0.970335
clinical trials0.629959
CLICK HERE
1637 National Cancer Institute Html en Coenzyme Q10 (PDQ®)–Patient Version Coenzyme Q10 is naturally made by the body and can be taken as a pill or injection. Studies have shown it to help protect the heart from damaging side effects of doxorubicin and to stimulate the immune system in cancer patients. Read about the results of clinical trials in cancer patients using coenzyme Q10 in this expert-reviewed summary.
cancer treatment0.549646
body0.488461
PDQ cancer information0.604928
Cancer Complementary0.504149
clinical trials0.78289
CoQ10 supplements0.61864
health care providers0.511973
mg CoQ100.629362
cancer information summary0.559761
alternative cancer therapies0.503732
clinical trial0.520374
CAM cancer research0.490752
free radicals0.529211
therapies0.527068
conventional cancer therapies0.505246
breast cancer patients0.577878
patients0.653188
cancer patients0.613167
adjuvant therapy0.48477
CoQ10 therapy0.668716
NCI PDQ cancer0.520611
cancer information database0.499763
CoQ10 analogs0.637275
Therapies Editorial Board0.506627
cancer information0.615008
treatment0.639358
cancer prevention0.483763
Complementary Therapies Editorial0.521183
CoQ100.914047
Drug Administration0.508672
Cancer Information Specialist0.495609
cancer cells0.510132
Cancer Information Service0.558797
treatment clinical trials0.486207
National Cancer Institute0.655789
studies0.570221
alternative medicine0.536733
health care0.547179
scientific journals0.497807
Federal Trade Commission0.485869
new treatment0.531574
Cancer Care page0.483491
breast cancer0.62622
animal studies0.506664
cancer clinical trials0.505899
alternative therapies0.521758
cancer information summaries0.500194
cancer0.924813
CLICK HERE
1901 National Cancer Institute Html es Tratamiento del glioma de tronco encefálico infantil (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento del glioma de tronco encefálico infantil.
siguientes procedimientos0.461896
IRM periódicas0.425856
posibles factores0.428641
efectos secundarios meses0.538429
encéfalo benignos0.484108
pontino intrínseco difuso0.901206
efectos tardíos0.636065
PDQ Efectos tardíos0.495055
National Cancer Institute0.428512
sustancia llamada gadolinio0.454314
siguientes riesgos0.420658
llamada neurofibromatosis tipo0.456821
Instituto Nacional0.447041
cinasa braf0.631095
presente sumario0.527425
PDQ Tratamiento0.518077
determinados cambios0.420201
neurofibromatosis tipo0.564203
nuevos tipos0.430533
sistema nervioso central0.564289
Physician Data Query0.500648
proteína braf0.427497
Aboutâ„¢ Brain Tumors0.435067
tumor dipg0.504754
siguientes enlaces0.422666
encefálico infantil recién0.732248
panel derecho0.429689
cuidado paliativo0.460842
siguientes sumarios0.465406
largo tiempo0.418821
siguientes trastornos0.430211
CLICK HERE
2027 National Cancer Institute Html es Prevención del cáncer colorrectal (PDQ®)–Versión para pacientes Sumario de información revisada por expertos sobre factores que influyen en el riesgo de presentar cáncer colorrectal y sobre las investigaciones dirigidas a prevenir esta enfermedad.
Problemas renales0.523957
siguientes factores0.953317
voluntarios sanos0.523051
Physician Data Query0.604817
siguientes afecciones0.551171
Estados Unidos0.609005
posibles daños0.574254
cuerpo).ampliar anatomía0.537676
suficiente ejercicio0.534096
prevención revisa0.526315
menor riesgo0.62051
PDQ Prevención0.545917
Antecedentes familiares0.532247
National Cancer Institute0.526671
tumores benignos0.586261
siguientes riesgos0.524072
siguientes sumarios0.58101
alto contenido0.561192
Instituto Nacional0.54913
CLICK HERE
3434 National Cancer Institute Html es Té y prevención de cáncer Hoja informativa que resume los resultados de estudios realizados sobre el té y la prevención del cáncer. Incluye información sobre los ingredientes del té y las consideraciones de seguridad sobre el consumo de esta bebida.
tea polyphenol levels0.306381
Gynecological Cancer0.306129
Zhang M0.301852
té oolong0.345261
lung cancer0.322075
green tea extract0.319452
case-control study0.308604
British Journal0.30281
Breast Cancer Research0.324861
Human Nutrition0.301844
verde activa enzimas0.302661
Singapore Chinese Health0.30349
tea polyphenol0.33584
black tea consumption0.317861
Inoue M0.303594
green tea rapidly0.307366
nested case-control study0.302496
PubMed Abstract0.999235
tea consumption0.35794
Women’s Health Study0.302821
green tea consumption0.326657
International Journal0.309091
Yang CS0.303196
cohort study0.312904
Chinese Health Study0.305698
Hakim IA0.303206
Drinking green0.302093
té verdeConcentración0.313111
Health Study0.306628
dietary intake0.301921
Ohsaki study0.302059
Cancer Research0.340725
Iwasaki M0.30184
Shanghai Cohort Study0.302687
prospective cohort study0.306347
subsequent risk0.303163
Clinical Nutrition0.305674
breast cancer0.401322
modestly reduces breast0.302193
tea consumption with0.307242
extract supplement0.301849
Cancer Institute0.306085
controlled study0.301969
Clinical Cancer Research0.312026
prospective study0.303895
green tea polyphenols0.325122
tea catechins after0.306288
Netherlands Cohort Study0.306092
té verde—500 mg0.313535
CLICK HERE
3515 National Cancer Institute Html en Types of Clinical Trials Information about the several types of cancer clinical trials, including treatment trials, prevention trials, screening trials, supportive and palliative care trials. Each type of trial is designed to answer different research questions.
agent studies0.634708
large number0.487416
treatment studies0.534627
unnecessary follow-up tests0.564207
standard treatments0.500667
palliative care trials0.620026
nutrition problems0.486132
approach prevent cancer0.592087
specific changes0.499234
researchers0.486118
cancer patients0.507417
treatment trials0.63562
Cancer prevention trials0.614093
healthy people0.501177
cancer screening trials0.613302
chemoprevention studies0.50869
health problems0.485883
high risk0.560244
radiation therapy0.500589
new ways0.649746
safe dose0.499447
life0.456389
answers questions0.498733
action studies0.564584
dietary supplements0.491505
studies0.663766
newer treatment trials0.614927
certain medicines0.490022
different research questions0.599262
new treatment0.895243
sleep disorders0.486249
disease0.456977
effective screening test0.579302
certain type0.487292
support groups0.492526
people0.64215
better quality0.492262
genetic changes0.499368
new treatment help0.724782
tumors0.439813
cancer clinical trials0.74573
new places0.514069
trials0.781895
treatment help people0.60481
cancer risk0.517947
cancer0.948957
prevention trials0.744319
new cancer0.533494
test new treatments0.617153
CLICK HERE
3650 National Cancer Institute Html en CRISPR: Genome Editing Comes of Age A research article about a technique for gene editing known as CRISPR-Cas9. The technique has made it much easier and faster for cancer researchers to study mutations and test new therapeutic targets.
next-generation DNA sequencing0.3795
new targets0.314335
activator-like effector nucleases0.397418
potentially druggable genes0.453893
future combination therapy0.360962
cancer therapy0.352224
unique gene0.31507
cancer growth0.426678
abnormal regulatory networks0.387625
cancer cell line0.572636
short palindromic repeats0.389333
genome editing0.387426
new therapeutic targets0.398394
genes0.545435
cell division0.314215
Cancer phenotypes0.335586
human cell0.318044
target genes0.365123
lymphoma cells0.394771
cancer drug targets0.463263
drug resistant tumors0.385077
David Baltimore0.313639
Ji Luo0.374003
drug resistance0.449373
DNA sequencing0.398873
potential combination therapies0.357658
possible therapeutic approaches0.357025
gene targets0.319574
gene expression—it0.322364
drug resistance question0.384228
CRISPR libraries0.319128
cancer cells0.810099
cancer cell lines0.446525
Dr. Luo0.937997
Dr. Staudt0.543567
CRISPR method0.325677
CRISPR technology0.334008
Hannover Medical School0.387381
Cancer Research0.352397
normal cells0.431696
cancer researchers0.367853
CRISPR0.510355
cell death0.314175
transformative technology0.318261
technology0.365907
Cancer Genome Atlas0.450206
gene editing0.330972
genetic changes0.316809
CLICK HERE
4383 National Cancer Institute Html en Anyone Can Get Skin Cancer No matter if your skin is light, dark, or somewhere in between, everyone is at risk for skin cancer. Learn what skin cancer looks like, how to find it early, and how to lower the chance of skin cancer.
skin cancer0.964567
UV rays0.456636
dark band0.53853
new mole0.452556
dark patch0.449539
body0.421991
waxy bump0.459872
Wear sunglasses0.448376
) bump.0.459875
talk0.420942
common sign0.451092
skin light0.47582
different types0.451536
jagged scar0.458002
exposure0.417645
medical conditions0.448166
sore0.426359
UVB rays0.455332
broad spectrum0.449203
women0.411421
UVA0.425118
sunscreen0.411184
high level0.447722
dark skin0.502452
changes0.445228
skin conditions0.464403
cancer cells0.45646
cell skin cancer0.522134
firm red lump0.495754
sun0.50802
skin tone0.480812
eyes0.41674
old growth0.501248
different color0.450303
men0.411424
certain medicines0.448412
advanced skin cancers0.508812
younger children0.460432
change0.452939
long sleeves0.44884
No.0.411646
skin ulcers0.466159
people0.446457
doctor0.48532
sunlight0.422273
cause damage0.452334
new growth0.497988
risk0.471314
low level0.448421
CLICK HERE
15481 National Cancer Institute Html en Non-NIH Funded Investigators Submitting Data null
large storage amounts0.821627
Institutional Certification0.889959
documents0.389667
hughessk@mail.nih.gov.0.612992
additional information/clarification0.581935
Institutional Certification forms0.830868
accession number0.58702
scientific community0.570468
Non-NIH funded investigators0.91136
completeness0.389773
DSPs0.387872
data submission process0.811324
GPA analyst registers0.892324
expectations0.444558
genomic data0.66091
value0.344731
DCB0.394534
data submission formats0.897528
NCI subcommittee0.653863
dbGaP submission0.557126
Basic Study Information0.821294
Shannon Hughes0.637978
steps0.351008
Studies0.345806
extramural GPAs0.729046
GDC staff0.659949
storage fee0.567724
plans0.351639
data submission0.961251
GPA analyst0.950832
consideration0.365649
Jennifer Strasburger0.670922
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.